BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29452841)

  • 1. Impact of age following treatment of severely calcified coronary lesions with the orbital atherectomy system: 3-year follow-up.
    Lee MS; Shlofmitz RA; Martinsen BJ; Sethi S; Chambers JW
    Cardiovasc Revasc Med; 2018 Sep; 19(6):655-659. PubMed ID: 29452841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus on procedural and one year clinical outcomes following treatment of severely calcified coronary lesions with the orbital atherectomy system: A subanalysis of the ORBIT II study.
    Lee MS; Martinsen BJ; Lee AC; Behrens AN; Shlofmitz RA; Kim CY; Chambers JW
    Catheter Cardiovasc Interv; 2018 May; 91(6):1018-1025. PubMed ID: 28733974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial.
    Lee M; Généreux P; Shlofmitz R; Phillipson D; Anose BM; Martinsen BJ; Himmelstein SI; Chambers JW
    Cardiovasc Revasc Med; 2017 Jun; 18(4):261-264. PubMed ID: 28162989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital atherectomy for the treatment of small (2.5mm) severely calcified coronary lesions: ORBIT II sub-analysis.
    Lee MS; Shlofmitz RA; Shlofmitz E; Srivastava PK; Kong J; Grines C; Revytak G; Chambers JW
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):268-272. PubMed ID: 29454531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital atherectomy treatment of severely calcified native coronary lesions in patients with prior coronary artery bypass grafting: Acute and one-year outcomes from the ORBIT II trial.
    Lee MS; Anose BM; Martinsen BJ; Lee AC; Shlofmitz RA; Chambers JW
    Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):498-502. PubMed ID: 29117920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study.
    Lee MS; Shlofmitz E; Shlofmitz R; Sahni S; Martinsen B; Chambers J
    J Invasive Cardiol; 2016 Sep; 28(9):364-9. PubMed ID: 26984932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions.
    Kim CY; Lee AC; Wiedenbeck TL; Lee MS; Chambers JW
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):671-7. PubMed ID: 26331279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of patients with myocardial infarction who underwent orbital atherectomy for severely calcified lesions.
    Lee MS; Shlofmitz E; Lluri G; Kong J; Neverova N; Shlofmitz R
    Cardiovasc Revasc Med; 2017; 18(7):497-500. PubMed ID: 28529094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program.
    Armstrong EJ; Stanislawski MA; Kokkinidis DG; Plomondon ME; Barón AE; Giri J; Shunk KA; Banerjee S; Maddox TM; Waldo SW
    Catheter Cardiovasc Interv; 2018 May; 91(6):1009-1017. PubMed ID: 28766833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in Elderly Patients With Severely Calcified Coronary Lesions Undergoing Orbital Atherectomy.
    Lee MS; Shlofmitz E; Lluri G; Shlofmitz RA
    J Interv Cardiol; 2017 Apr; 30(2):134-138. PubMed ID: 28116818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
    de Waha S; Allali A; Büttner HJ; Toelg R; Geist V; Neumann FJ; Khattab AA; Richardt G; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):691-700. PubMed ID: 26525804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-Based Differences in Outcomes After Orbital Atherectomy for the Treatment of De Novo Severely Calcified Coronary Lesions.
    Lee MS; Shlofmitz E; Mansourian P; Sethi S; Shlofmitz RA
    J Invasive Cardiol; 2016 Nov; 28(11):440-443. PubMed ID: 27801655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in Diabetic Patients Undergoing Orbital Atherectomy System.
    Lee MS; Shlofmitz E; Nguyen H; Shlofmitz RA
    J Interv Cardiol; 2016 Oct; 29(5):491-495. PubMed ID: 27489020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital Atherectomy for Treating De Novo Severely Calcified Coronary Narrowing (1-Year Results from the Pivotal ORBIT II Trial).
    Généreux P; Lee AC; Kim CY; Lee M; Shlofmitz R; Moses JW; Stone GW; Chambers JW
    Am J Cardiol; 2015 Jun; 115(12):1685-90. PubMed ID: 25910525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial).
    Bhatt P; Parikh P; Patel A; Chag M; Chandarana A; Parikh R; Parikh K
    Cardiovasc Revasc Med; 2014 Jun; 15(4):204-8. PubMed ID: 24746600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II).
    Chambers JW; Feldman RL; Himmelstein SI; Bhatheja R; Villa AE; Strickman NE; Shlofmitz RA; Dulas DD; Arab D; Khanna PK; Lee AC; Ghali MG; Shah RR; Davis TP; Kim CY; Tai Z; Patel KC; Puma JA; Makam P; Bertolet BD; Nseir GY
    JACC Cardiovasc Interv; 2014 May; 7(5):510-8. PubMed ID: 24852804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Impaired Renal Function in Patients With Severely Calcified Coronary Lesions Treated With Orbital Atherectomy.
    Lee MS; Shlofmitz E; Lluri G; Shlofmitz RA
    J Invasive Cardiol; 2017 Jun; 29(6):203-206. PubMed ID: 28089999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy.
    Lee MS; Shlofmitz E; Kaplan B; Shlofmitz R
    J Invasive Cardiol; 2016 Apr; 28(4):147-50. PubMed ID: 27031936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.